Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
483 Leser
Artikel bewerten:
(2)

Appian: Survey Reveals Dutch Companies ESG Aspirations Constrained By Data Silos and Fragmented Processes

Finanznachrichten News

As many as 95% of respondents in the Netherlands have data challenges

AMSTERDAM, Jan. 10, 2023 /PRNewswire/ -- According to a new survey conducted by Direct Research and commissioned by Appian, Dutch companies aspire to improve their environmental, social, and governance (ESG) initiatives but 95% of respondents have data challenges and fragmented processes. The survey went to professionals at mid-size companies with at least 250 employees in the Netherlands. Respondents were asked about the use of data and the role of ESG processes within their company and its customer service department.

Appian helps organizations build apps and workflows rapidly, with a low-code automation platform. Combining people, technologies, and data in a single workflow, Appian can help companies maximize their resources and improve business results. Many of the world's largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk management and compliance. To learn more, visit www.appian.com.

Support from management for ESG initiatives is high with 85% expressing support for ESG goals and policies. Organisations have aspirational goals to improve customer service and four in five (82%) survey respondents indicated that environmental, social, and governance (ESG) plays a part. Specifically:

- 46% shared that their company already invests in a social corporate culture.

- 42% invest in green initiatives within the company.

- 37% have green investments outside of the organisation.

"ESG practices are constantly subject to regulatory changes," commented Herbert Schild, Global Industry Lead in Financial Services at Appian. "The underlying detailed requirements for processes, data volumes, and their quality will only rise and become increasingly complex in the future. Regardless of what your ESG relevant use case may be, you need a flexible enterprise platform and automate as much as possible to reduce the technical debt that ESG related regulations and requirements typically demand."

While the desire to build better ESG processes is already high, improved collaboration and oversight are both crucial to successful implementation. Almost half of those surveyed (46%) say they struggle to implement ESG within the company, and 38% state that collaboration between different departments is a stumbling block. In addition, one in three respondents have challenges complying with local and international regulations and ESG reporting.

For many survey respondents, these issues are due to disconnected systems within their organisation. These silos hinder data collection (75%) and introduce too many data reporting (64%) and deployment (66%) challenges. In addition, as many as 95% of respondents said they encounter one or more challenges in the following areas:

- Analysing data (49%)

- Automating processes (45%)

- Collecting data (33%)

- Reporting of data (33%)

Automation solutions are recognized as useful for implementing ESG-conscious processes within organisations by uniting existing systems (43%). Additionally, the ability to quickly adapt to ESG criteria and regulations using low-code applications is high on the wish list for a third of employees in the survey.

"It is good to see that most people understand the value of data. However, it is worrying that hundreds of Dutch organisations are encountering challenges when it comes to deploying it for the good of the business," said Marten Kruisinga, Regional VP of Benelux and Nordics at Appian. "Organisations could extract more value from their data by using an enterprise process automation platform interwoven with a data fabric that eliminates data silos to simplify data collection and analysis."

Download the Dutch survey here to read the full study.

About the Report
Conducted by research firm DirectResearch, the Appian commissioned survey received responses from 306 Dutch professionals in 2022 who are decision-makers in the fields of marketing, sales, IT, management, customer service, product development and legal.

About Appian
Appian is the unified platform for change. We accelerate customers' businesses by discovering, designing, and automating their most important processes. The Appian Low-Code Platform combines the key capabilities needed to get work done faster, Process Mining + Workflow + Automation, in a unified low-code platform. Appian is open, enterprise-grade, and trusted by industry leaders. For more information, visit appian.com.

Follow Appian: Twitter, LinkedIn.

Logo - https://mma.prnewswire.com/media/1488235/Appian_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/survey-reveals-dutch-companies-esg-aspirations-constrained-by-data-silos-and-fragmented-processes-301717323.html

© 2023 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.